Please assess the completion status of the following clinical trial:

Trial Title: Correlation of Renal Mass Pathologic Grade and Contrast Enhanced Ultrasound (CEUS)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Greater than or equal to 18 years of age~* Previously identified renal mass with radiology and clinical features consistent with RCC~* Clinical care plan includes partial or total nephrectomy~Exclusion Criteria:~* Less than 18 years of age~* Currently pregnant~* Renal mass with clinical care plan that does not include nephrectomy~* Renal mass suspected to be non RCC neoplasm by imaging and clinical data~* Renal mass unable to be visualized by grayscale ultrasound~* Known renal vein thrombosis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Renal malignancy (Type: EXPERIMENTAL): Patients with renal mass(es) identified by cross sectional imaging, specifically ultrasound following the intravenous injection of Lumason

Based on this trial design, predict the completion outcome and termination type (if applicable).